BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11979824)

  • 1. [Second line treatment regimen of PPI + AMPC + MNZ for patients with clarithromycin-resistant Helicobacter pylori infection].
    Tokunaga K; Takahashi S
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():445-8. PubMed ID: 11979824
    [No Abstract]   [Full Text] [Related]  

  • 2. [Second-line eradication therapy for H. pylori infection--PPI+AMPC+MNZ triple therapy].
    Okimoto T; Murakami K; Fujioka T
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():435-7. PubMed ID: 16363574
    [No Abstract]   [Full Text] [Related]  

  • 3. [Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection].
    Inoue K; Sugano K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():460-4. PubMed ID: 11979828
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections].
    Kagaya H; Kato M; Asaka M
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():455-9. PubMed ID: 11979827
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dual therapy for Helicobacter pylori resistance to anti microbial agents].
    Fu HY; Kawano S; Tanimura H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():423-6. PubMed ID: 11979819
    [No Abstract]   [Full Text] [Related]  

  • 6. [Selection of antibiotics and planning of eradication for H. pylori infection].
    Murakami K; Satoh R; Okimoto T; Kagawa J; Fujioka T; Kodama M
    Nihon Rinsho; 2001 Feb; 59(2):308-13. PubMed ID: 11218403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication].
    Mitsuno Y; Yoshida H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():452-4. PubMed ID: 11979826
    [No Abstract]   [Full Text] [Related]  

  • 8. [High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy].
    Shirai N; Furuta T; Sugimoto M; Nakamura A
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():438-41. PubMed ID: 16363575
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].
    Nagahara A; Sato N
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():421-5. PubMed ID: 16363572
    [No Abstract]   [Full Text] [Related]  

  • 10. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
    Nagahara A; Miwa H; Kawabe M; Kurosawa A; Asaoka D; Hojo M; Iijima K; Terai T; Ohkusa T; Miyazaki A; Sato N
    J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].
    Tsukada K; Katoh H; Miyazaki T; Kuwano H
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():486-8. PubMed ID: 16363585
    [No Abstract]   [Full Text] [Related]  

  • 12. [Helicobacter pylori eradication therapy for children].
    Konno M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():470-3. PubMed ID: 16363581
    [No Abstract]   [Full Text] [Related]  

  • 13. [Establishment of 2nd line treatment regimen for H. pylori infection--future prospect for the application for national health insurance system in Japan].
    Fujioka T
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():27-30. PubMed ID: 16363499
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of PPI/AM re-treatment regimen for the patients with Helicobacter pylori infection after failure of first line eradication therapy by PPI/AC regimens].
    Nagahara A; Miyazaki A; Miwa H; Sato N
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():435-8. PubMed ID: 11979822
    [No Abstract]   [Full Text] [Related]  

  • 15. [Guidelines in the management of H. pylori infection in Japan].
    Asaka M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():12-6. PubMed ID: 16363496
    [No Abstract]   [Full Text] [Related]  

  • 16. [PPI plus bismuth-based quintuple therapy].
    Kimura K; Hiratsuka T; Tamura K; Hiratsuka H; Suzuki T; Bray R
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():452-8. PubMed ID: 16363577
    [No Abstract]   [Full Text] [Related]  

  • 17. [Triple therapy for eradication of Helicobacter pylori in Japan].
    Takeda H
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():409-13. PubMed ID: 16363569
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adverse effects of Helicobacter pylori eradication and its prevention].
    Zhang S; Yanaka A
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():414-7. PubMed ID: 16363570
    [No Abstract]   [Full Text] [Related]  

  • 19. Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
    Fennerty MB
    Am J Gastroenterol; 1998 Jan; 93(1):2-3. PubMed ID: 9448162
    [No Abstract]   [Full Text] [Related]  

  • 20. [Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection].
    Ohkusa T; Sato N
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():431-4. PubMed ID: 11979821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.